Skip to main content

Find Clinical Trials

Home
Conditions
Retinal Diseases

Clinical trial condition

Retinal Diseases

Explore clinical trials studying Retinal Diseases. Study availability and eligibility vary by location and protocol.

2,349 public trials 292 recruiting studies

Refine in advanced search Browse all conditions

Retinal Diseases trial results

Completed

Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors

NCT00515814

Conditions: Blindness, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +12 more
Locations: Eye Hospital Dresden-Friedrichstadt Dresden, Germany

University Eye Hospital Tuebingen Tübingen, Germany

View Trial Details

Completed

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

NCT00492284

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
Locations: Mobile, Alabama, United States

Phoenix, Arizona, United States

Retina Centers, PC Tucson, Arizona, United States

Beverly Hills, California, United States

View all 26 locations

View Trial Details

Completed

Retinopathy of Prematurity:Summary of a Decade

NCT01363960

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Infant, Newborn, Diseases, +3 more
Locations: Gulhane Military Medical School Training Hospital Ankara, Turkey (Türkiye)

View Trial Details

Completed

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

NCT00239928

Conditions: Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
Locations: Pfizer Investigational Site Nagoya, Aichi-ken, Japan

Pfizer Investigational Site Urayasu, Chiba, Japan

Pfizer Investigational Site Fukuoka, Japan

Pfizer Investigational Site Fukushima, Japan

View Trial Details

Completed

Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)

NCT00109499

Conditions: Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
Locations: Retina-Vitreous Associates Medical Group Beverly Hills, California, United States

Retinal Transplantation Laboratory Los Angeles, California, United States

UCLA - Jules Stein Eye Research Center Los Angeles, California, United States

Florida Eye Microsurgical Institute, Inc. Boynton Beach, Florida, United States

View Trial Details

Completed

Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization

NCT01350323

Conditions: Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations: University of Molise Campobasso, Italy

View Trial Details

Completed

Vitrectomy for Optic Disc Pit Maculopathy

NCT01340703

Conditions: Eye Diseases, Optic Disc Pit Maculopathy, Retinal Degeneration, +4 more
Locations: Kyroin University Eye Center Mitaka, Tokyo, Japan

View Trial Details

Completed

Clinicopathologic Findings for Macular Disease

NCT00994227

Conditions: Eye Diseases, Macular Degeneration, Macular Disease, +2 more
Locations: JiWon Lim Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy

NCT00674323

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +11 more
Locations: Novartis Investigative Site Hong Kong

Novartis Investigative Site Singapore

Novartis Investigative Site Seoul, South Korea

Novartis Investigative Site Taipei, Taiwan

View Trial Details

Completed

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

NCT00436553

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
Locations: Novartis Investigative Site Tucson, Arizona, United States

Novartis Investigative Site Beverly Hills, California, United States

Novartis Investigative Site Oakland, California, United States

Novartis Investigative Site Pasadena, California, United States

View all 43 locations

View Trial Details